ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The primary objective is to assess the event-free survival defined as the time from randomisation to progression, death without progression, loss to follow up, whichever occurred first..
Epistemonikos ID: 74a78bb5c8382b7d85e80b704c9edeadd0ca46e7
First added on: May 05, 2024